Skip to contentC
ClearPoint Neuro, Inc.
C
CLPTClearPoint Neuro, Inc. Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$10.41M$10.41Mderived+34.0% vs Q4 2024 Net Income-$7.79M-$7.79MderivedN/M vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ClearPoint Neuro, Inc. · CIK 1285550 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$6,404,000+34.5% Operating Incomederived-$7,045,000N/M Operating Cash Flowderived-$12,055,000N/M Free Cash Flowderived-$12,104,000N/M Margins · derivedGross margin61.5%+0.2 pt vs Q4 2024
Operating margin-67.7%+4.9 pt vs Q4 2024
Net margin-74.8%−5.5 pt vs Q4 2024
ended Dec 31, 2025 · filed Mar 17, 2026 · 76 d after period end